Apiam Animal Health (ASX:AHX) has reported its full-year revenue of A$192.8 million, which indicates a 22.6% rise.

The company highlighted the resilience of its business model and forecasts improved operating earnings margins in FY24.

Further margin opportunities have been spotted in several clinics.

There was an 11.6% jump in the full-year underlying EBITA to A$12.8 million.

The National Australia Bank agreed to prolong the existing terms of the company’s debt facilities until January 2026.

The underlying NPATA of the year was A$6.4 million, compared to A$7.1 million from the previous year.

Apiam Animal Health (ASX:AHX) is a veterinary health service provider with a wide range of services catering to various animal species.